Welcome to Westonci.ca, the Q&A platform where your questions are met with detailed answers from experienced experts. Get quick and reliable solutions to your questions from a community of experienced experts on our platform. Get precise and detailed answers to your questions from a knowledgeable community of experts on our Q&A platform.
Sagot :
Clinical practitioners in the United States continue to underutilize inhaled corticosteroids in the management of mild-to-moderate adult asthma.
In a cohort of patients aged 18 and older with FEV(1) values between 60% and 100% of predicted normal, the aim of this experiment was to determine the clinical effects, health-related quality of life, cost, and cost-effectiveness of inhaled corticosteroid therapy.
We compared the use of inhaled corticosteroid therapy along with quick relievers (such as short-acting beta-agonists) on an as-needed basis to the use of quick relievers alone.
To predict symptoms, acute exacerbations, quality-adjusted life years (QALYs), health care expenses, and cost-effectiveness, evaluated in both dollars per QALY gained and dollars per symptom-free day gained, a mathematical simulation model was created.
Learn more about corticosteroids:
https://brainly.com/question/28255810
#SPJ4
The complete question is '' what is the cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model''.
Thank you for choosing our service. We're dedicated to providing the best answers for all your questions. Visit us again. We appreciate your time. Please revisit us for more reliable answers to any questions you may have. Your questions are important to us at Westonci.ca. Visit again for expert answers and reliable information.